Global Psoriatic Arthritis Market 2023
The report covers market size and growth, segmentation, competitive landscape, trends and strategies for global psoriatic arthritis market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
Market Segmentation
The market is segmented based on various factors, including drug class, disease type, gender type, age group, severity type, and geography.
Drug class: interleukin inhibitors, NSAIDs, TNF inhibitors, others
Disease type: spondylitis, dactylitis, enthesitis
Gender: men, women
Age group: 50 years and below, 50 years and above
Severity type: moderate, mild, severe
Segmentation by Geography
North America US
Europe Germany, France, UK, Italy, Spain
APAC - China, Japan
TNF-Alpha inhibitors dominate the global psoriatic arthritis treatment market but the fastest growth is expected in interleukin inhibitors. Approvals of drugs like Skyrizi and Cosentyx will drive the market. Women make up a significant portion of the market due to increased risk. Enthesitis holds a significant share but Dactylitis will grow the fastest. Individuals below 50 will make up a substantial portion. Mild form is significant but moderate form will grow the fastest. The United States dominates the market due to affordability, knowledge, and technology. Germany will experience rapid growth due to healthcare access and awareness. Biosimilars in China and Japan will bring changes. China has the highest number of cases, followed by Spain and the U.K. PsA prevalence is increasing in the European Union.
Competitive Landscape
Major players in the global psoriatic arthritis treatment market include AbbVie Inc, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Biogen Inc, UCB SA, Amgen Inc., Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly and Company, and Novartis AG. These companies are employing strategies such as collaborations, acquisitions, geographic expansion, research and development, and manufacturing novel drugs to strengthen their product portfolios and compete in the market. Other notable players include Bausch Health Companies Inc., Biocad Biopharmaceutical Co., Bio-Thera Solutions, Ltd., Eli Lilly and Company, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Meiji Holdings Co., Ltd., Sun Pharmaceuticals Industries Limited, among others. These players prioritize research and development to develop advanced psoriatic drugs and maintain their industry position.
Scope of the Report
To analyze and forecast the market size of the global psoriatic arthritis market.
To classify and forecast the global psoriatic arthritis market based on drug class, disease type, gender, age group, severity type, geography.
To identify drivers and challenges for the global psoriatic arthritis market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global psoriatic arthritis market.
To identify and analyze the profile of leading players operating in the global psoriatic arthritis market.
Why Choose This Report
Gain a reliable outlook of the global psoriatic arthritis market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Companies Mentioned
AbbVie Inc, Amgen Inc., Bausch Health Companies Inc., Biocad Biopharmaceutical Co., Biogen Inc, Bio-Thera Solutions Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Jiangsu Hengrui Pharmaceuticals Co. Ltd., Johnson & Johnson, Meiji Holdings Co. Ltd., Novartis AG, Pfizer Inc., Sun Pharmaceuticals Industries Limited, Takeda Pharmaceutical Company Limited, UCB SA
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL PSORIATIC ARTHRITIS MARKET BY DRUG CLASS
5.1 Interleukin inhibitors
5.2 NSAIDs
5.3 TNF inhibitors
5.4 Others
PART 6. GLOBAL PSORIATIC ARTHRITIS MARKET BY DISEASE TYPE
6.1 Spondylitis
6.2 Dactylitis
6.3 Enthesitis
PART 7. GLOBAL PSORIATIC ARTHRITIS MARKET BY GENDER
7.1 Men
7.2 Women
PART 8. GLOBAL PSORIATIC ARTHRITIS MARKET BY AGE GROUP
8.1 50 years and below
8.2 50 years and above
PART 9. GLOBAL PSORIATIC ARTHRITIS MARKET BY SEVERITY TYPE
9.1 Moderate
9.2 Mild
9.3 Severe
PART 10. GLOBAL PSORIATIC ARTHRITIS MARKET BY GEOGRAPHY
10.1 North America
10.2 Europe
10.3 APAC
PART 11. COMPANY PROFILES
11.1 AbbVie Inc
11.2 Amgen Inc.
11.3 Bausch Health Companies Inc.
11.4 Biocad Biopharmaceutical Co.
11.5 Biogen Inc
11.6 Bio-Thera Solutions, Ltd.
11.7 Bristol-Myers Squibb Company
11.8 Eli Lilly and Company
11.9 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
11.10 Johnson & Johnson
11.11 Meiji Holdings Co., Ltd.
11.12 Novartis AG
11.13 Pfizer Inc.
11.14 Sun Pharmaceuticals Industries Limited
11.15 Takeda Pharmaceutical Company Limited
11.16 UCB SA
DISCLAIMER
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View ReportGlobal Psoriatic Arthritis Therapeutics Market Research Report 2021-2025
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Psoriatic Arthritis Therapeutics Report by Material, Application, and
USD 3200 View ReportGlobal Psoriatic Arthritis Therapeutics Market Research Report 2019-2023
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Psoriatic Arthritis Therapeutics Report by Material, Application, and
USD 2850 View ReportFill The Form For Sample Request